Role of CCR2+ Myeloid Cells in Pulmonary Inflammation Responses Driven by Expression of a Surfactant Protein-C Mutant in the Alveolar Epithelium

Abstract

Abstract Acute inflammatory exacerbations (AIE) represent precipitous deteriorations of a number of chronic lung conditions, including pulmonary fibrosis (PF), COPD, and asthma. AIEs are marked by diffuse and persistent polycellular alveolitis that profoundly accelerate lung function decline and mortality. Excess monocyte mobilization during AIE and their persistence in the lung are linked to poor disease outcome. Guided by clinical evidence, we have developed a mutant model of pulmonary fibrosis leveraging the PF-linked missense isoleucine to threonine substitution at position 73 [I73T] in the alveolar type-2 cell-restricted Surfactant Protein-C [SP-C] gene [SFTPC]. With this toolbox at hand, the present work investigates the role of resident alveolar macrophages and peripheral monocytes during the initiation and progression of AIE-PF. Genetic ablation of CCR2+ monocytes (SP-C I73TCCR2KO) resulted in improved lung histology, mouse survival, and reduced inflammation compared to SP-C I73TCCR2WT cohorts FACS analysis of SigF+CD11b− alveolar macrophages and Ly6Chi monocytes isolated 3 d and 14 d after SP-CI73T induced injury reveals dynamic transcriptional changes associated with “Innate Immunity’ and ‘ECM Remodeling” signaling. In situ hybridization analysis revealed comparable levels of tgfb1 mRNA expression localized primarily in parenchymal cells in parenchymal cells found nearby foci of injury. We also observed partial tgfb1 mRNA colocalization in iNOS+ and Arg1+ activated cells in SP-CI73TCCR2WT mice, but not in SP-CI73TCCR2KO lungs. Together, these results provide a detailed picture on the role of resident macrophages and recruited monocytes in the context of AIE-PF driven by alveolar epithelial dysfunction.